Petros Pharmaceuticals Inc (PTPI) — Financial Flexibility Index
Petros Pharmaceuticals Inc (PTPI) has a Financial Flexibility Index of -0.05x as of March 2025. Free cash flow of $-1.49 Million (operating CF $-1.49 Million minus capex $0.00) represents 0% of total liabilities ($27.19 Million). Check PTPI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Petros Pharmaceuticals Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Petros Pharmaceuticals Inc across 7 annual periods. See Petros Pharmaceuticals Inc (PTPI) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Petros Pharmaceuticals Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Petros Pharmaceuticals Inc. For the full company profile including market capitalisation, see Petros Pharmaceuticals Inc (PTPI) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.14x | $-2.58 Million | $-2.60 Million | $18.10 Million | ▲ +60.2% |
| 2023 | -0.36x | $-7.63 Million | $-7.63 Million | $21.32 Million | ▲ +56.1% |
| 2022 | -0.81x | $-12.80 Million | $-12.80 Million | $15.72 Million | ▼ -118.6% |
| 2021 | -0.37x | $-11.86 Million | $-11.86 Million | $31.85 Million | ▼ -27.5% |
| 2020 | -0.29x | $-15.30 Million | $-15.31 Million | $52.38 Million | ▼ -664.7% |
| 2019 | 0.05x | $2.60 Million | $2.53 Million | $50.35 Million | ▼ -64.2% |
| 2018 | 0.14x | $9.90 Million | $8.02 Million | $68.57 Million | — |